National Diabetes Institute, voco Kuching by IHG, Kuching, Sarawak, Malaysia
15/10/2026 to 17/10/2026
The Continuing Professional Development (CPD) Series as “Diabetes Asia 2026” Conference aims to help improve management of diabetes with emphasis on recent advances and practical aspects of diabetes care.
Participants are expected to be able to: • appreciate recent advances, practical aspects of diabetes care. • understand ways of ensuring early diagnosis and optimal management for good control of diabetes, complications and associated diseases • apply knowledge gained during the Conference & Workshops to further improve care for persons with diabetes in the community
PLENARY TOPICS
A. CONFIRMED 1. Increased Risk Of Cancer-An Integral Component Of The Cardio Renal Metabolic Disease Cluster And Its Management. 2. The New Diabetes Playbook : Obesity-First, Kidney-Smart, Heart-Failure-Ready, Tech-Enabled. 3. Role Of Basal Insulin In T2DM; History And Re-Evaluation. 4. Regional Adiposity: Genetics,Metabolic Consequences And Treatment. 5. Improving Risk Prediction For Chronic Kidnes Disease Complicating Type 2 Diabetes. B. Tentative 5 Topics awaiting confirmation from International speakers SYMPOSIUM THEMES/ TOPICS 1. Therapeutics: GLP-1 Receptor Agonists 2. New Approach: Long- acting cardiometabolic therapies 3. Advances in Managing Diabetes in Children & Adolescents (wearable devices, Prevention) 4. Roles of other healthcare professionals (primary care Physicians, Clinical pharmacists, Diabetes Educators) 5. Early detection and management of diabetic complications (Kidneys, Eyes, Nerves) 6. Advances in Managing Heart Diseases Associated with Diabetes 7. The Future of Diabetes Technologies (sensors, algorithms, smart pens) 8. Nutrition, Diet and ?Exercise Pill 9. The Quest to Prevent or Cure diabetes 10. newer drugs in the pipeline for diabetes and associated diseases FREE PAPER PRESENTATION Free paper presentation is open for all aspects (clinical and scientific) of research relating to diabetes, its complications and co-morbidities. There will be two categories: Oral and Poster Presentation.
|